CLINICAL_TRIALS
trial_result
· 2015-02-24
Clinical Trial Update: Extension Study for 2993-112 [Phase 3]
Summary
This update notes the completion of the extension study for AstraZeneca's Phase 3 trial 2993-112 in Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED